Group 1: Epidemic Overview - The recent outbreak of Chikungunya fever in southern China has led to nearly 3,000 new cases reported in just one week, primarily in Guangdong province, affecting over ten cities [1][3] - The majority of cases are concentrated in Foshan, accounting for 95% of the total cases in Guangdong, with no severe cases or deaths reported so far [3] Group 2: Government Response and Guidelines - The National Health Commission has released the "Chikungunya Fever Diagnosis and Treatment Plan (2025 Edition)," emphasizing that the disease is preventable, controllable, and treatable [3][7] - The plan incorporates traditional Chinese medicine (TCM) approaches, highlighting the role of TCM in alleviating symptoms and promoting recovery [7] Group 3: Company Initiatives - Several listed companies in the IVD (in vitro diagnostics) sector are actively developing testing products and treatment solutions for Chikungunya fever [2][4] - Shenzhen BGI Technology Co., Ltd. has introduced the T1+ gene sequencer, which can rapidly analyze samples with low viral loads, aiding in precise epidemic control [2][4] - Wanfu Biology has developed multiple testing products for Chikungunya virus detection, creating a closed-loop system for rapid screening and monitoring [4] Group 4: Traditional Chinese Medicine Applications - TCM is being utilized for symptomatic treatment of Chikungunya fever, with specific formulations recommended for managing high fever and other severe symptoms [7][8] - Companies like Guangdong Yifang Pharmaceutical and others are producing traditional Chinese medicines that have shown efficacy in treating similar viral infections [8]
十城迎战基孔肯雅热：IVD企业24小时研发出检测盒 中药巨头紧急调配抗疫古方
Hua Xia Shi Bao·2025-08-07 03:27